GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (XTER:EWL) » Definitions » Long-Term Debt

Edwards Lifesciences (XTER:EWL) Long-Term Debt : €538 Mil (As of Sep. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Edwards Lifesciences Long-Term Debt?

Edwards Lifesciences's Long-Term Debt for the quarter that ended in Sep. 2024 was €538 Mil.

Edwards Lifesciences's quarterly Long-Term Debt increased from Mar. 2024 (€549 Mil) to Jun. 2024 (€555 Mil) but then declined from Jun. 2024 (€555 Mil) to Sep. 2024 (€538 Mil).

Edwards Lifesciences's annual Long-Term Debt increased from Dec. 2021 (€527 Mil) to Dec. 2022 (€563 Mil) but then declined from Dec. 2022 (€563 Mil) to Dec. 2023 (€547 Mil).

Edwards Lifesciences Long-Term Debt Historical Data

The historical data trend for Edwards Lifesciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Long-Term Debt Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 534.96 489.09 527.20 562.91 547.45

Edwards Lifesciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 559.20 547.45 549.42 554.89 538.35

Edwards Lifesciences  (XTER:EWL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Edwards Lifesciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (XTER:EWL) » Definitions » Long-Term Debt
Comparable Companies
DXCM ZBH STE PODD GMED PEN BIO MASI BRKR GKOS ABT SYK BSX MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH
Traded in Other Exchanges
EW:USA EW:Mexico 1EW:Italy EWL:Germany EWL:Germany E1WL34:Brazil EWLS:Austria
Address
One Edwards Way, Irvine, CA, USA, 92614
Website
https://www.edwards.com
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.